Global 5-Alpha Reductase Deficiency Market at a rate of CAGR of 6.80 %in the forecast period 2022 to 2029

5-alpha reductase deficiency is a rare sex development disorder (DSD) characterized by incomplete intrauterine masculinization, ranging from female genitalia with a blind vaginal pouch to a fully male phenotype with pseudovaginal posterior hypospadias and micropenis, and caused by a defect in metabolizing testosterone to dihydrotestosterone.

Mutations in the SRD5A2-gene (2p23.1) allow the steroid 5 alpha-reductase type 2 enzyme, which converts testosterone into DHT in the external genitalia, to work poorly or not at all, resulting in the condition.

 As a result, male differentiation does not occur throughout fetal development despite high amounts of testosterone in the blood. The levels of residual enzymatic function determine the manifestations at birth.

Get the sample copy of the Report


  • Data Bridge Market Research analyses that the 5-alpha reductase deficiency market was valued at USD 1.08 billion in 2021 and is expected to reach USD 1.83 billion by 2029, registering a CAGR of 6.80% during the forecast period of 2022 to 2029. 
  • To bring about this report, primary and secondary research methodologies have been employed for a detailed study.
  • Researchers and analysts have also estimated key milestones achieved by the global 5-Alpha Reductase Deficiency Market and associated them with the current market trends to give the readers a holistic picture of the market.
  • This market document performs a SWOT analysis of major key players in the Global 5-Alpha Reductase Deficiency Market industry based on strengths, weaknesses, opportunities, and threats as well as the company’s internal & external environments.
  • This Global 5-Alpha Reductase Deficiency Market research report evaluates the current as well as future performance of the market, and also brand-new trends in the market.
  • The market report is an important element that gains demand from all corners of the globe. It provides a product overview and highlights product and application segments of the global market including price, revenue, sales, sales growth rate, and market share by product.
  • In this Global 5-Alpha Reductase Deficiency Market report, a section on the competitive landscape of the key players operating in the global market has also been covered. Moreover, this industry report lists and studies the leading competitors and also provides insights into the strategic industry analysis of the key factors influencing the market dynamics.

Customization Available


Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Factbook) or can assist you in creating presentations from the data sets available in the report.


5-Alpha Reductase Deficiency Market Scope

The 5-alpha reductase deficiency market is segmented based on diagnosis, treatment, age of onset, end-users, and distribution channel. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.


Chromosome Analysis

Gene Sequencing

Hormone Tests

Imaging Tests



Genetic Screening





Feminizing genitoplasty

Hormone Replacement Therapy


Age of Onset







Specialty Clinics



Distribution Channel

Hospital Pharmacy

Retail Pharmacy

Online Pharmacy



5-Alpha Reductase Deficiency Market Regional Analysis/Insights

The 5-alpha reductase deficiency market is analyzed and market size insights and trends are provided by country, diagnosis, treatment, age of onset, end-users, and distribution channel as referenced above.

The countries covered in the 5-alpha reductase deficiency market report are the U.S., Canada, and Mexico in North America, Germany, France, the U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of the Middle East and Africa (MEA) as a part of the Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America

Competitive Landscape and 5-Alpha Reductase Deficiency Market Share Analysis

The 5-alpha reductase deficiency market competitive landscape provides details on a competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only rand elated to the companies' focus related to the 5-alpha reductase deficiency market.

Some of the major players operating in the 5-alpha reductase deficiency market are:

  1. Hoffmann-La Roche Ltd. (Switzerland)

Mylan N.V. (US)

Sanofi (France)

Pfizer Inc. (US)

GlaxoSmithKline plc (UK)

Novartis AG (Switzerland)

Bayer AG (Germany)

Eli Lilly and Company (US)

Merck & Co., Inc. (US)Allergan (Ireland)

Abbott (US)

Merck KGaA (Germany)

Alma Lasers (Israel)

ELECTRONIC (South Korea)

ThermiGen, LLC. (US)

Viveve Solutions (US)

Venus Concept (Canada)

Fotona (Slovenia)

Almirall, S.A (Spain)

Hologic, Inc. (US)

Novo Nordisk A/S (Denmark)


Get Full Access to the Report

Asia-Pacific is expected to grow during the forecast period of 2022-2029 due to the development of healthcare infrastructure in this region. Also, rising government initiatives will further propel the 'market's growth rate in this region.


Chapter One: Introduction

Chapter Two: Market Segmentation

Chapter Three: Market Overview

Chapter Four: Executive Summary

Chapter Five: Premium Insights

Chapter Six Global 5-Alpha Reductase Deficiency Market 


Get TOC Reports



Browse Related Reports

About Us

Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market



Data Bridge Market Research

Tel: +1-888-387-2818